Skip to content
value.today

Duo Oncology Inc.

🇺🇸 Pittsburgh, Pennsylvania, USAPharmaceuticalsFounded 2020
Total raised
$7 M
3 rounds on record
Latest round
$2 M
Jun 2025
First round on record
Feb 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Duo Oncology Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2025$2 MNo. 3Under $2 million

Duo Oncology Inc.: Raise no. 3, Jun 2025

Investors in this round

13 investors had bought by the notice of Aug 7, 2026: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jing-Zhou Hou · Executive Officer, Director, Promoter
  • Katherine Eichinger · Executive Officer
  • Sam Rothstein · Executive Officer, Director, Promoter
  • Stephen Thorne · Executive Officer, Promoter
  • Joe Gatto · Director
  • Lusong Luo · Director
  • Song Li · Director, Promoter
  • Stanley Marks · Director
  • Victoria Manax · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sam Rothstein, President and CEO. Newest notice filed Aug 7, 2026. Read the notice at the SEC.

debt, optionsSEC
Jan 2023$4 MNo. 2$2 to $10 million

Duo Oncology Inc.: Raise no. 2, Jan 2023

Investors in this round

14 investors had bought by the notice of Aug 11, 2023: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$150,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jing-Zhou Hou · Executive Officer, Promoter
  • Sam Rothstein · Executive Officer, Director, Promoter
  • Stephen Thorne · Executive Officer, Promoter
  • Robert Ashley · Director
  • Song Li · Director, Promoter
  • Stanley Marks · Director
  • Jingjing Sun · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts include conversion of SAFEs (Simple Agreements for Future Equity).”

Signed by Sam Rothstein, President and CEO. Newest notice filed Aug 11, 2023 (1 amendment). Read the notice at the SEC.

equitySEC
Feb 2021$1 MNo. 1Under $2 million

Duo Oncology Inc.: Raise no. 1, Feb 2021

Investors in this round

1 investor had bought by the notice of Feb 8, 2021: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them, other: Simple Agreement for Future Equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$145,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jing-Zhou Hou · Executive Officer, Director, Promoter
  • Sam Rothstein · Executive Officer, Director, Promoter
  • Stephen Thorne · Executive Officer, Director, Promoter
  • Song Li · Director, Promoter
  • Stanley Marks · Director
  • Jingjing Sun · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sam Rothstein, President and CEO. Newest notice filed Feb 8, 2021. Read the notice at the SEC.

optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Duo Oncology Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).

    SEC Form D · Aug 2026

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Aug 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Duo Oncology Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Duo Oncology Inc.
NameRoleNamed in
Jing-Zhou HouExecutive officerAug 2026
Katherine EichingerExecutive officerAug 2026
Sam RothsteinExecutive officerAug 2026
Stephen ThorneExecutive officerAug 2026
Jing-Zhou HouDirectorAug 2026
Joe GattoDirectorAug 2026
Lusong LuoDirectorAug 2026
Sam RothsteinDirectorAug 2026
Song LiDirectorAug 2026
Stanley MarksDirectorAug 2026
Victoria ManaxDirectorAug 2026
Robert AshleyDirectorAug 2023
Stephen ThorneDirectorFeb 2021
Jing-Zhou HouPromoterAug 2026
Sam RothsteinPromoterAug 2026
Song LiPromoterAug 2026
Stephen ThornePromoterAug 2026
Jingjing SunPromoterAug 2023